Reverse signaling from LIGHT promotes pro-inflammatory responses in the human monocytic leukemia cell line, THP-1

Cellular Immunology

Volumn 285, Issue 1-2, 2013, Pages 10-17

  Lim, Su Geun ^a   Suk, Kyoungho ^b   Lee, Won Ha ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

IL 8; Inflammation; LIGHT; Macrophage; MMP 9; Reverse signaling

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIGHT PROTEIN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL THP 1; CELL ADHESION; CELL MIGRATION; CELL STIMULATION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFLAMMATION; LEUKEMIA CELL LINE; MACROPHAGE; MONOCYTIC LEUKEMIA; PHAGOCYTOSIS; PRIORITY JOURNAL; WESTERN BLOTTING;

IL-8; INFLAMMATION; LIGHT; MACROPHAGE; MMP-9; REVERSE SIGNALING;

CELL ADHESION; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-8; MACROPHAGES; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; PHAGOCYTOSIS; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14; ZYMOSAN;

EID: 84884187126     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.08.002     Document Type: Article

References (54)

1. Mauri D.N., Ebner R., Montgomery R.I., Kochel K.D., Cheung T.C., Yu G.L., Ruben S., Murphy M., Eisenberg R.J., Cohen G.H., Spear P.G., Ware C.F. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 1998, 8:21-30.
2. Rooney I.A., Butrovich K.D., Glass A.A., Borboroglu S., Benedict C.A., Whitbeck J.C., Cohen G.H., Eisenberg R.J., Ware C.F. The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J. Biol. Chem. 2000, 275:14307-14315.
3. Yu K.Y., Kwon B., Ni J., Zhai Y., Ebner R., Kwon B.S. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J. Biol. Chem. 1999, 274:13733-13736.
4. Tamada K., Shimozaki K., Chapoval A.I., Zhu G., Sica G., Flies D., Boone T., Hsu H., Fu Y.X., Nagata S., Ni J., Chen L. Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat. Med. 2000, 6:283-289.
5. Tamada K., Shimozaki K., Chapoval A.I., Zhai Y., Su J., Chen S.F., Hsieh S.L., Nagata S., Ni J., Chen L. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J. Immunol. 2000, 164:4105-4110.
6. Harrop J.A., McDonnell P.C., Brigham-Burke M., Lyn S.D., Minton J., Tan K.B., Dede K., Spampanato J., Silverman C., Hensley P., DiPrinzio R., Emery J.G., Deen K., Eichman C., Chabot-Fletcher M., Truneh A., Young P.R. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J. Biol. Chem. 1998, 273:27548-27556.
7. Wan X., Zhang J., Luo H., Shi G., Kapnik E., Kim S., Kanakaraj P., Wu J. A TNF family member LIGHT transduces costimulatory signals into human T cells. J. Immunol. 2002, 169:6813-6821.
8. Shi G., Luo H., Wan X., Salcedo T.W., Zhang J., Wu J. Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood 2002, 100:3279-3286.
9. Bai C., Connolly B., Metzker M.L., Hilliard C.A., Liu X., Sandig V., Soderman A., Galloway S.M., Liu Q., Austin C.P., Caskey C.T. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc. Natl. Acad. Sci. USA 2000, 97:1230-1235.
10. Ferran C., Dautry F., Merite S., Sheehan K., Schreiber R., Grau G., Bach J.F., Chatenoud L. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo. J. Clin. Invest. 1994, 93:2189-2196.
11. Stuber E., Strober W., Neurath M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 1996, 183:693-698.
12. van Essen D., Kikutani H., Gray D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 1995, 378:620-623.
13. Chen N.J., Huang M.W., Hsieh S.L. Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine. J. Immunol. 2001, 166:270-276.
14. Cerutti A., Schaffer A., Goodwin R.G., Shah S., Zan H., Ely S., Casali P. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells. J. Immunol. 2000, 165:786-794.
15. Suzuki I., Fink P.J. The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells. Proc. Natl. Acad. Sci. USA 2000, 97:1707-1712.
16. Chou A.H., Tsai H.F., Lin L.L., Hsieh S.L., Hsu P.I., Hsu P.N. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. J. Immunol. 2001, 167:1347-1352.
17. Eissner G., Kirchner S., Lindner H., Kolch W., Janosch P., Grell M., Scheurich P., Andreesen R., Holler E. Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages. J. Immunol. 2000, 164:6193-6198.
18. Bae E.M., Kim W.J., Suk K., Kang Y.M., Park J.E., Kim W.Y., Choi E.M., Choi B.K., Kwon B.S., Lee W.H. Reverse signaling initiated from GITRL induces NF-kappaB activation through ERK in the inflammatory activation of macrophages. Mol. Immunol. 2008, 45:523-533.
19. Jeon S.T., Kim W.J., Lee S.M., Lee M.Y., Park S.B., Lee S.H., Kim I.S., Suk K., Choi B.K., Choi E.M., Kwon B.S., Lee W.H. Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells. Immunol. Cell Biol. 2010, 88:148-156.
20. Lee S.M., Kim E.J., Suk K., Lee W.H. BAFF and APRIL induce inflammatory activation of THP-1 cells through interaction with their conventional receptors and activation of MAPK and NF-kappaB. Inflamm. Res. 2011, 60:807-815.
21. Lee S.M., Jeon S.T., Kim W.J., Suk K., Lee W.H. Macrophages express membrane bound form of APRIL that can generate immunomodulatory signals. Immunology 2010, 131:350-356.
22. Lee S.M., Kim E.J., Suk K., Lee W.H. Stimulation of FasL induces production of pro-inflammatory mediators through activation of mitogen activated protein kinases and nuclear factor-kappaB in THP-1 cells. Inflammation 2012, 35:1-10.
23. Sun C.C., Cheng C.Y., Chien C.S., Pang J.H., Ku W.C., Chen P.Y., Yang C.M. Role of matrix metalloproteinase-9 in ex vivo expansion of human limbal epithelial cells cultured on human amniotic membrane. Invest. Ophthalmol. Vis. Sci. 2005, 46:808-815.
24. Edwards J.R., Sun S.G., Locklin R., Shipman C.M., Adamopoulos I.E., Athanasou N.A., Sabokbar A. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis. Arthritis Rheum. 2006, 54:1451-1462.
25. Zhang Y.L., Dong C. MAP kinases in immune responses. Cell. Mol. Immunol. 2005, 2:20-27.
26. Dong C., Davis R.J., Flavell R.A. MAP kinases in the immune response. Annu. Rev. Immunol. 2002, 20:55-72.
27. Koyasu S. The role of PI3K in immune cells. Nat. Immunol. 2003, 4:313-319.
28. Oeckinghaus A., Hayden M.S., Ghosh S. Crosstalk in NF-kappaB signaling pathways. Nat. Immunol. 2011, 12:695-708.
29. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004, 18:2195-2224.
30. Wahl C., Liptay S., Adler G., Schmid R.M. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J. Clin. Invest. 1998, 101:1163-1174.
31. Han Y., Englert J.A., Yang R., Delude R.L., Fink M.P. Ethyl pyruvate inhibits nuclear factor-{kappa}B-dependent signaling by directly targeting p65. J. Pharmacol. Exp. Ther. 2005, 312:1097-1105.
32. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J. 1995, 9:726-735.
33. Gunzl P., Bauer K., Hainzl E., Matt U., Dillinger B., Mahr B., Knapp S., Binder B.R., Schabbauer G. Anti-inflammatory properties of the PI3K pathway are mediated by IL-10/DUSP regulation. J. Leukoc. Biol. 2010, 88:1259-1269.
34. Cen L., Hsieh F.C., Lin H.J., Chen C.S., Qualman S.J., Lin J. PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound. Br. J. Cancer 2007, 97:785-791.
35. Weichhart T., Saemann M.D. The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann. Rheum. Dis. 2008, 67(Suppl. 3):iii70-iii74.
36. Kim W.J., Kang Y.J., Koh E.M., Ahn K.S., Cha H.S., Lee W.H. LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro-inflammatory cytokines and MMP-9 in macrophages. Immunology 2005, 114:272-279.
37. Kang Y.M., Kim S.Y., Kang J.H., Han S.W., Nam E.J., Kyung H.S., Park J.Y., Kim I.S. LIGHT up-regulated on B lymphocytes and monocytes in rheumatoid arthritis mediates cellular adhesion and metalloproteinase production by synoviocytes. Arthritis Rheum. 2007, 56:1106-1117.
38. Lee W.H., Kim S.H., Lee Y., Lee B.B., Kwon B., Song H., Kwon B.S., Park J.E. Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler. Thromb. Vasc. Biol. 2001, 21:2004-2010.
39. Wang J., Lo J.C., Foster A., Yu P., Chen H.M., Wang Y., Tamada K., Chen L., Fu Y.X. The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J. Clin. Invest. 2001, 108:1771-1780.
40. Zhang J., Salcedo T.W., Wan X., Ullrich S., Hu B., Gregorio T., Feng P., Qi S., Chen H., Cho Y.H., Li Y., Moore P.A., Wu J. Modulation of T-cell responses to alloantigens by TR6/DcR3. J. Clin. Invest. 2001, 107:1459-1468.
41. Cochran J.R., Aivazian D., Cameron T.O., Stern L.J. Receptor clustering and transmembrane signaling in T cells. Trends Biochem. Sci. 2001, 26:304-310.
42. Goodridge H.S., Underhill D.M., Touret N. Mechanisms of Fc receptor and dectin-1 activation for phagocytosis. Traffic 2012, 13:1062-1071.
43. Adhikary S., Kocieda V.P., Yen J.H., Tuma R.F., Ganea D. Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression. Blood 2012, 120:3741-3749.
44. Creighton C., Hanash S. Expression of matrix metalloproteinase 9 (MMP-9/gelatinase B) in adenocarcinomas strongly correlated with expression of immune response genes. In Silico Biol. 2003, 3:301-311.
45. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 1994, 55:97-179.
46. Baggiolini M., Dewald B., Moser B. Human chemokines: an update. Annu. Rev. Immunol. 1997, 15:675-705.
47. Zeilhofer H.U., Schorr W. Role of interleukin-8 in neutrophil signaling. Curr. Opin. Hematol. 2000, 7:178-182.
48. Kollias G., Kontoyiannis D. Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments. Cytokine Growth Factor Rev. 2002, 13:315-321.
49. Pfeffer K. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev. 2003, 14:185-191.
50. Reichner J.S., Fitzpatrick P.A., Wakshull E., Albina J.E. Receptor-mediated phagocytosis of rat macrophages is regulated differentially for opsonized particles and non-opsonized particles containing beta-glucan. Immunology 2001, 104:198-206.
51. Liao G., Simon S.R. Temporal down-regulation of Fc gamma RIII expression and Fc gamma receptor-mediated phagocytosis in human monocyte-derived macrophages induced by TNF-alpha and IL-1 beta. J. Leukoc. Biol. 1994, 55:702-710.
52. Willment J.A., Lin H.H., Reid D.M., Taylor P.R., Williams D.L., Wong S.Y., Gordon S., Brown G.D. Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J. Immunol. 2003, 171:4569-4573.
53. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
54. Osman N., Lucas S., Cantrell D. The role of tyrosine phosphorylation in the interaction of cellular tyrosine kinases with the T cell receptor zeta chain tyrosine-based activation motif. Eur. J. Immunol. 1995, 25:2863-2869.